Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara–vectored Ebola vaccines at 1 year
RL Winslow, ID Milligan, M Voysey, K Luhn… - Jama, 2017 - jamanetwork.com
Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara–Vectored
Ebola Vaccines at 1 Year | Global Health | JAMA | JAMA Network [Skip to Navigation] Our
website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue,"
you are agreeing to our Cookie Policy | Continue JAMA Network Home Access Provided by
Google Scholar JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA
Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal …
Ebola Vaccines at 1 Year | Global Health | JAMA | JAMA Network [Skip to Navigation] Our
website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue,"
you are agreeing to our Cookie Policy | Continue JAMA Network Home Access Provided by
Google Scholar JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA
Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal …